Pancreatic cancer has recently been included in the list of diseases about which Brazil's National Cancer Institute (INCA) ...
Immunovia (STO: IMMNOV), the pancreatic cancer diagnostics company, today announces the successful completion of the CLARITI study, (Clinical Validation of Next-Generation Test for Early-Stage ...
Cancer cells are like booming cities without urban planners. They expand quickly, and in doing so, the resulting tumors ...
FDA approves Merus' Bizengri as the first treatment for advanced NRG1 fusion-positive cancers. U.S. peak sales are estimated ...
BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne ...
Merus N.V. (MRUS) announced that the U.S. Food and Drug Administration has granted accelerated approval for BIZENGRI ...
Merus (MRUS) announced that the FDA approved BIZENGRI(R) (zenocutuzumab-zbco), the first and only treatment indicated for ...
Merus’ Bizengri receives US FDA approval to treat pancreatic adenocarcinoma or non–small cell lung cancer: Utrecht, The Netherlands Friday, December 6, 2024, 15:30 Hrs [IST] M ...